The Gut Microbiome Affects Atherosclerosis by Regulating Reverse Cholesterol Transport

Area of Science:

• Microbiology
• Cardiovascular Science
• Metabolomics

Background:

• The gut microbiome, a complex ecosystem of microorganisms, plays a crucial role in human health.
• Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of mortality, imposing a significant healthcare burden.
• Growing evidence links alterations in gut microbial composition and metabolites to ASCVD development.

Purpose of the Study:

• To review the intricate relationship between the gut microbiota, its metabolites, and reverse cholesterol transport (RCT).
• To explore the potential of targeting the gut microbiome and its metabolites as a therapeutic strategy for atherosclerosis.

Main Methods:

• Literature review synthesizing current research on gut microbiota and RCT.
• Analysis of microbial metabolites involved in cholesterol homeostasis.
• Exploration of therapeutic interventions targeting the gut microbiome.

Main Results:

• The gut microbiota significantly influences RCT, a key mechanism preventing cholesterol accumulation.
• Specific microbial metabolites have been identified that modulate RCT pathways.
• Gut microbiota composition is altered in individuals at risk for atherosclerosis.

Conclusions:

• The gut microbiome is a critical factor in regulating RCT and influencing ASCVD.
• Modulating the gut microbiota and its metabolites presents a promising avenue for novel atherosclerosis therapies.
• Further research into gut-heart axis interactions can lead to innovative cardiovascular disease prevention and treatment strategies.